Â
INDEPENDENT BUSINESS VALUATION FIRM
INDEPENDENT BUSINESS VALUATION FIRM
Defensible
Business Valuations
Defensible
Business Valuations
Independent 409A, ASC 805, ASC 820, ASC 718, goodwill impairment, fairness opinion, and gift & estate valuations — built on rigorous DCF, market, and asset-based methodology.
Client Satisfaction
0
%
Client Satisfaction
0
%
Client Satisfaction
0
%
OUR SERVICES
Comprehensive Valuation Services
Independent, defensible valuations across the full spectrum of financial reporting, tax, and transaction needs.
ASC 805
Purchase Price Allocations
Allocation of purchase consideration to acquired assets and assumed liabilities for business combinations.
ASC 350
Goodwill Impairments
Annual and triggering-event impairment testing of goodwill and indefinite-lived intangible assets.
ASC 820
Portfolio Valuation
Fair value measurement of illiquid investments for funds, family offices, and institutional investors.
SPAC & M&A
Fairness Opinions
Independent opinions on the financial fairness of transactions for boards and special committees.
IRS Compliant
Gift & Estate Valuations
Defensible valuations of business interests for gift, estate, and wealth transfer planning.
Expert Testimony
Litigation & Dispute
Valuation analysis and expert witness services for shareholder disputes, divorce, and damages.
IRC 409A
409A Valuations
Independent valuations of common stock for private companies issuing equity-based compensation.
ASC 718
Stock Compensation
Fair value measurement of equity awards including options, RSUs, and performance-based grants.
Methodology
Three Proven Approaches
We employ industry-leading valuation methodologies to deliver accurate, defensible business valuations.
DCF
Discounted Cash Flow
Project future cash flows and discount them to present value. The gold standard for intrinsic valuation.
Comps
Comparable Analysis
Benchmark against similar companies using market multiples like EV/EBITDA and P/E ratios.
NAV
Asset-Based Approach
Calculate net asset value by adjusting book values of assets and liabilities to fair market value.
Defensible valuations, delivered with rigor.
Independent 409A, ASC 805, ASC 820, ASC 718, goodwill impairment, fairness opinion, and gift & estate valuations — built on rigorous DCF, market, and asset-based methodology.
Independent & Objective
No audit, advisory, or transaction conflicts. Our opinions stand on their own merits and withstand scrutiny from auditors, regulators, and the IRS.
Independent & Objective
No audit, advisory, or transaction conflicts. Our opinions stand on their own merits and withstand scrutiny from auditors, regulators, and the IRS.
Independent & Objective
No audit, advisory, or transaction conflicts. Our opinions stand on their own merits and withstand scrutiny from auditors, regulators, and the IRS.
Independent & Objective
No audit, advisory, or transaction conflicts. Our opinions stand on their own merits and withstand scrutiny from auditors, regulators, and the IRS.
Industries We Serve
Sector-Specific Valuation Expertise
Defensible business valuations require more than methodology — they require deep industry knowledge. Ares Advisors brings specialized expertise across regulated, capital-intensive, and high-growth sectors, with featured practices in cannabis and oil & gas.
Independent & Objective
No audit, advisory, or transaction conflicts. Our opinions stand on their own merits and withstand scrutiny from auditors, regulators, and the IRS.
Credentialed Expertise
Our team holds ASA, CFA, and ABV credentials with decades of combined experience in financial reporting, tax, and transaction valuation.
Sector Specialization
Biotech, medtech, digital health, and provider group valuations with milestone risk and probability-weighted cash flow modeling.
Healthcare & Life Sciences
Biotech, medtech, digital health, and provider group valuations with milestone risk and probability-weighted cash flow modeling.
Quick Estimate
Estimate Your Value
Get an instant preliminary estimate. For a comprehensive valuation, schedule a consultation with our team.
Preliminary Estimated Value
$0
This is a rough, automated estimate for directional purposes only. It does not constitute a formal valuation opinion. Schedule a consultation for a defensible, credentialed report.
Testimonials
Trusted by Leaders
★★★★★
"Ares Advisors' valuation was instrumental in our Series B fundraise. Their thoroughness gave our investors complete confidence."
CEO, TechScale Inc.
★★★★★
"The Ares Advisors team delivered a comprehensive valuation report that exceeded our expectations. Highly professional and detail-oriented."
CFO, GreenLeaf Holdings
★★★★★
"We engaged Ares Advisors for our M&A transaction and the valuation stood up perfectly under due diligence scrutiny."
Partner, Meridian Capital
Methadology
Ready to Discover Your True Value?
Our methodology adapts to any sector. Reach out to discuss your specific
valuation needs.